Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 6/2019

01-06-2019 | Research Article

Laparoscopy adjuvant total colorectal resection for the treatment of familial adenomatous polyposis (FAP)

Authors: Z. Zhang, D. Wang, C. Xu, Y. Yu, Y. Li, X. Zhang

Published in: Clinical and Translational Oncology | Issue 6/2019

Login to get access

Abstract

Objective

To discuss and evaluate the safety and value of laparoscopy adjuvant total colorectal resection for the treatment of familial adenomatous polyposis (FAP).

Methods

From March 2010 to June 2015, 38 cases were retrospectively analyzed and divided into 2 groups, of which 17 cases used laparoscopy adjuvant total colorectal resection, and 21 cases used conventional laparotomy. Clinical data were obtained, and the safety and prognosis were observed.

Results

Seventeen cases using laparoscopy adjuvant total colorectal resection achieved success with no conversion to laparotomy and intraoperative complications. There was no significant difference in operation time between the two groups. There were significant differences in blood loss, the length of incision, postoperative recovery time of intestinal function and postoperative hospital stay between the two groups (P < 0.05). The trauma in laparoscopy group was less, and could recover faster, and there was no significant difference in complications between the two groups. In addition, there were no recurrence, distant metastasis and death in the follow-up period from 6 to 56 months.

Conclusion

Laparoscopy adjuvant total colorectal resection is more safe and feasible, which has minimal invasion and can recover fast.
Literature
1.
Wirtzfeld DA, Petrelli NJ, Rodriguezbigas MA. Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol. 2001;8:319–27.CrossRefPubMed
2.
Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, Lau MW, Lu KH, Roach N, Limburg PJ. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol. 2015;33:209–17.CrossRefPubMed
3.
Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology. 2003;124:544–60.CrossRef
4.
Nezhat FR, Ezzati M, Chuang L, Shamshirsaz AA, Rahaman J, Gretz H. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome. Am J Obstet Gynecol. 2009;200:1–6.CrossRef
5.
Ghezzi F, Cromi A, Uccella S, Bergamini V, Tomera S, Franchi M, Bolis P. Laparoscopy versus laparotomy for the surgical management of apparent early stage ovarian cancer. Gynecol Oncol. 2007;105:409–13.CrossRefPubMed
6.
Borowski DW, Baker EA, Wilson D, Garg DK, Gill TS. Clinical outcomes and inflammatory response to single-incision laparoscopic (SIL) colorectal surgery: a single-blinded randomised-controlled pilot study. Colorectal Dis. 2018. https://​doi.​org/​10.​1111/​codi.​14435.
7.
8.
Yang X, Zhong ME, Xiao Y, Zhang GN, Xu L, Lu J, Lin G, Qiu H, Wu B. Laparoscopic vs open resection of pT4 colon cancer: a propensity score analysis of 94 patients. Colorectal Dis. 2018;20:O316–25.CrossRefPubMed
9.
Marcello PW, Milsom JW, Wong SK, Hammerhofer KA, Goormastic M, Church JM, Fazio VW. Laparoscopic restorative proctocolectomy: case-matched comparative study with open restorative proctocolectomy. Dis Colon Rectum. 2000;43:604–8.CrossRefPubMed
10.
Chowdhury S, Ferdous A, Bhuiyan AH, Nandy A. Laparoscopy versus conventional laparotomy for the management of tubal ectopic pregnancy—a randomized controlled trial. Bjog An Int J Obstet Gynaecol. 2013;1:35–8.
11.
Nunez Nunez R, Galan Gomez E, Moreno Hurtado C, Romero Albillo A, Santamaria Ossorio JI. Familial adenomatous polyposis: Gardner’s syndrome. Cir Pediatr. 2006;19:111–4.PubMed
12.
13.
Church J. Ileoanal pouch neoplasia in familial adenomatous polyposis: an underestimated threat. Dis Colon Rectum. 2005;48:1708–13.CrossRefPubMed
14.
Nylund G, Oresland TS, Nordgren S. Long-term outcome after colectomy in severe idiopathic constipation. Colorectal Dis. 2001;3:253–8.CrossRefPubMed
15.
Ramosvaladez DI, Patel CB, Ragupathi M, Bartley PT, Haas EM. Single-incision laparoscopic right hemicolectomy: safety and feasibility in a series of consecutive cases. Surg Endosc. 2010;24:2613–6.CrossRef
16.
Moloo H, Haggar F, Martel G, Grimshaw J, Coyle D, Graham ID, Sabri E, Poulin EC, Mamazza J, Balaa FK. The adoption of laparoscopic colorectal surgery: a national survey of general surgeons. Can J Surg J Can De Chir. 2009;52:455–62.
17.
Campos FG, Real Martinez CA, Monteiro de Camargo MG, Cesconetto DM, Nahas SC, Cecconello I. Laparoscopic versus open restorative proctocolectomy for familial adenomatous polyposis. J Laparoendosc Adv Surg Tech A. 2018;28:47–52.CrossRefPubMed
18.
Otsuka K, Itabashi T, Sasaki A, Kimura T, Kato K, Wakabayashi G. Laparoscopic-assisted proctocolectomy with prolapsing technique for familial adenomatous polyposis. Surg Laparosc Endosc Percutan Tech. 2014;24:e228–32.PubMed
19.
Campos FG, Araujo SE, Melani AG, Pandini LC, Nahas SC, Cecconello I. Surgical outcomes of laparoscopic colorectal resections for familial adenomatous polyposis. Surg Laparosc Endosc Percutan Tech. 2011;21:327–33.CrossRefPubMed
20.
Papaconstantinou HT, Thomas JS. Single-incision laparoscopic colectomy for cancer: assessment of oncologic resection and short-term outcomes in a case-matched comparison with standard laparoscopy. Surgery. 2011;150:820–7.CrossRefPubMed
21.
Geisler D, Garrett T. Single incision laparoscopic colorectal surgery: a single surgeon experience of 102 consecutive cases. Tech Coloproctol. 2011;15:397–401.CrossRefPubMed
Metadata
Title
Laparoscopy adjuvant total colorectal resection for the treatment of familial adenomatous polyposis (FAP)
Authors
Z. Zhang
D. Wang
C. Xu
Y. Yu
Y. Li
X. Zhang
Publication date
01-06-2019
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 6/2019
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-018-1979-0

Other articles of this Issue 6/2019

Clinical and Translational Oncology 6/2019 Go to the issue

Review Article

Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives

Research Article

Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

Correction

Correction to: SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)

Research Article

Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy

Research Article

The protective effects of melatonin on blood cell counts of rectal cancer patients following radio-chemotherapy: a randomized controlled trial

Brief Research Article

Statin treatment and outcomes of metastatic pancreatic cancer: a pooled analysis of two phase III studies
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits